Theratechnologies Inc T.TH

Alternate Symbol(s): THTX

Healthcare Biotechnology

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.

TSX:TH - Post by User

Theratechnologies Inc > Something big is likely in the works

<< Previous

Bullboard Posts

Next >>

Comment by palinc2000on Jan 08, 2022 8:59am

162 Views

Post# 34295866

RE:RE:RE:RE:RE:RE:RE:RE:Something big is likely in the works

Most of The positions advertised dont seem to have been filled so that would not be a problem but I dont think that a buyout is very likely at this stage...I am still wondering why a Meeting has been called with apparently no known agenda and no list of all participants.It cant be about running the business or discussing material info not yet disclosed to the public.... That leaves the other iption which is raising capital by way of a Private Placement .... hard to comment on that without knowing the terms ..